RAS mutations are found in approximately 30% of human tumors [36], with K-RAS mutations being the most frequent (70–90% of pancreatic cancer, 50% of colon cancer, 25–50% of lung adenocarcinoma) [29, 30, 32]. This evidence concerns the gene KRAS and lung adenocarcinoma.